SCHEMBL30980479

SCHEMBL30980479

COCCN1CCN([C@H]2CO[C@H](CO)[C@H](O)[C@@H]2O)C1=O

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 2/20 0.34
▸ CDA P32320 4/20 0.31
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23705384 0.81 CDA (0.35) GBA1CDA
SCHEMBL23705229 0.71 CDA (0.43) GBA1CDA
SCHEMBL26900891 0.71 CDA (0.43) GBA1CDA
SCHEMBL30980794 0.71 MAOA (0.41) GBA1CDA
SCHEMBL24256513 0.69 CDA (0.36) GBA1CDA
SCHEMBL23705157 0.69 CDA (0.42) GBA1CDA
SCHEMBL26879290 0.69 CDA (0.51) GBA1CDA
SCHEMBL23705041 0.69 CDA (0.36) GBA1CDA
SCHEMBL24256694 0.69 CDA (0.51) GBA1CDA
SCHEMBL27115334 0.69 CDA (0.42) GBA1CDA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback